S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial by Koizumi, Wasaburo, Dr, Narahara, Hiroyuki, MD, Hara, Takuo, MD, Takagane, Akinori, MD, Akiya, Toshikazu, MD, Takagi, Masakazu, MD, Miyashita, Kosei, MD, Nishizaki, Takashi, MD, Kobayashi, Osamu, MD, Takiyama, Wataru, MD, Toh, Yasushi, MD, Nagaie, Takashi, MD, Takagi, Seiichi, MD, Yamamura, Yoshitaka, MD, Yanaoka, Kimihiko, MD, Orita, Hiroyuki, MD, Takeuchi, Masahiro, ScD

Get full text

Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study by Boku, Narikazu, Dr, Yamamoto, Seiichiro, PhD, Fukuda, Haruhiko, MD, Shirao, Kuniaki, Prof, Doi, Toshihiko, MD, Sawaki, Akira, MD, Koizumi, Wasaburo, MD, Saito, Hiroshi, MD, Yamaguchi, Kensei, MD, Takiuchi, Hiroya, MD, Nasu, Junichiro, MD, Ohtsu, Atsushi, MD

Get full text